无创通气与经鼻高流量氧疗联合呼吸暂停氧合用于急性低氧性呼吸衰竭患者插管前预氧合的随机对照试验
FLORALI-2多中心开放标签随机对照试验在法国28个ICU纳入313例急性低氧性呼吸衰竭需气管插管患者,比较无创通气与经鼻高流量氧疗预氧合对插管过程中严重低氧血症的影响。总体严重低氧血症发生率两组无显著差异(23% vs 27%),但在PaO2/FiO2≤200 mmHg亚组中无创通气组严重低氧血症发生率显著低于高流量氧疗组(24% vs 35%)。
要点
- 急性低氧性呼吸衰竭插管前预氧合,无创通气与高流量氧疗总体严重低氧血症风险无差异。
- PaO2/FiO2≤200 mmHg亚组中,无创通气预氧合可降低插管中严重低氧血症风险。
- 两组严重不良事件无差异,常见即刻并发症为收缩压降低和胸部X线浸润影。
核心结论
- 在急性低氧性呼吸衰竭患者中,无创通气与高流量氧疗预氧合未改变插管过程中严重低氧血症的风险。
- 在基线中重度低氧血症(PaO2/FiO2≤200 mmHg)患者中,无创通气预氧合后严重低氧血症发生率低于高流量氧疗。
研究设计与样本
- FLORALI-2为多中心、开放标签、随机对照试验,在法国28个ICU进行。
- 成人急性低氧性呼吸衰竭(PaO2/FiO2≤300 mmHg)需气管插管患者按1:1随机分配至无创通气或高流量氧疗预氧合,按PaO2/FiO2(≤200 vs >200 mmHg)分层。
- 共322例入组,313例纳入意向性治疗分析,无创通气组142例,高流量氧疗组171例。
主要发现
- 常见即刻并发症为收缩压降低(无创通气组49% vs 高流量氧疗组50%)和胸部X线浸润影(20% vs 19%)。
- 常见晚期并发症为第28天死亡(37% vs 34%)和ICU期间呼吸机相关性肺炎(22% vs 20%)。
关键数值与推荐
- 纳入标准:成人急性低氧性呼吸衰竭需气管插管,PaO2/FiO2≤300 mmHg。
- 排除标准包括心脏骤停插管、格拉斯哥昏迷评分<8分、无创通气禁忌证(近期咽喉/食管/胃手术、严重面部骨折)、无法获取脉搏血氧饱和度、妊娠或哺乳期、拒绝参与。
- 主要结局为插管过程中严重低氧血症(脉搏血氧饱和度<80%),在意向性治疗人群中评估。
临床怎么用
- 对于急性低氧性呼吸衰竭需插管患者,可选择无创通气或高流量氧疗进行预氧合。
- 对基线PaO2/FiO2≤200 mmHg的中重度低氧血症患者,优先考虑无创通气预氧合以降低插管中严重低氧血症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-invasive ventilation has never been compared with high-flow oxygen to determine whether it reduces the risk of severe hypoxaemia during intubation. We aimed to determine if preoxygenation with non-invasive ventilation was more efficient than high-flow oxygen in reducing the risk of severe hypoxaemia during intubation. METHODS: The FLORALI-2 multicentre, open-label trial was done in 28 intensive care units in France. Adult patients undergoing tracheal intubation for acute hypoxaemic respiratory failure (a partial pressure of arterial oxygen [PaO2] to fraction of inspired oxygen [FiO2] ratio of ≤300 mm Hg) were randomly assigned (1:1; block size, four participants) to non-invasive ventilation or high-flow oxygen during preoxygenation, with stratification by PaO2/FiO2 ratio (≤200 mm Hg vs >200 mm Hg). Key exclusion criteria were intubation for cardiac arrest, altered consciousness (defined as a Glasgow coma score of less than eight points), other contraindications to non-invasive ventilation (recent laryngeal, oesophageal, or gastric surgery, and substantial facial fractures), pulse oximetry not available, pregnant or breastfeeding women, and refusal to participate. The primary outcome was the occurrence of severe hypoxaemia (pulse oximetry <80%) during the procedure, assessed in the intention-to-treat population. This trial is registered with ClinicalTrials.gov, number NCT02668458. FINDINGS: Between April 15, 2016, and Jan 8, 2017, 2079 patients were intubated in the 28 participating units, and 322 were enrolled. We excluded five patients with no recorded data, two who withdrew consent or were under legal protection, one who was not intubated, and one who had a cardiac arrest. Of the 313 patients included in the intention-to-treat analysis, 142 were assigned to non-invasive ventilation and 171 to high-flow oxygen therapy. Severe hypoxaemia occurred in 33 (23%) of 142 patients after preoxygenation with non-invasive ventilation and 47 (27%) of 171 with high-flow oxygen (absolute difference -4·2%, 95% CI -13·7 to 5·5; p=0·39). In the 242 patients with moderate-to-severe hypoxaemia (PaO2/FiO2 ≤200 mm Hg), severe hypoxaemia occurred less frequently after preoxygenation with non-invasive ventilation than with high-flow oxygen (28 [24%] of 117 patients vs 44 [35%] of 125; adjusted odds ratio 0·56, 0·32 to 0·99, p=0·0459). Serious adverse events did not differ between treatment groups, with the most common immediate complications being systolic arterial hypotension (70 [49%] patients in the non-invasive ventilation group vs 86 [50%] patients in the high-flow oxygen group) and chest infiltrate on x-ray (28 [20%] vs 33 [19%]), and the most common late complications being death at day 28 (53 [37%] vs 58 [34%]) and ventilator-associated pneumonia during ICU stay (31 [22%] vs 35 [20%]). INTERPRETATION: In patients with acute hypoxaemic respiratory failure, preoxygenation with non-invasive ventilation or high-flow oxygen therapy did not change the risk of severe hypoxaemia. Future research should explore the effect of preoxygenation method in patients with moderate-to-severe hypoxaemia at baseline. FUNDING: French Ministry of Health.
引用
- Frat JP, Ricard JD, Quenot JP, et al. Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trial. Lancet Respir Med. 2019. PMID: 30898520. doi:10.1016/S2213-2600(19)30048-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。